妊娠期贫血严重程度与母婴不良结局
该回顾性队列研究利用中国医院质量监测系统2016年1月1日至2019年12月31日的数据,纳入中国大陆1508家有产科服务的医院中15至49岁、已报告分娩结局的孕妇。贫血按血红蛋白浓度分级:轻度100至109 g/L、中度70至99 g/L、重度低于70 g/L。在18 948 443例孕妇中,17.78%诊断妊娠期贫血,其中轻度9.04%、中度2.62%、重度0.21%、严重程度不明5.90%。校正社会人口学特征和其他妊娠并发症后,贫血严重程度与胎盘早剥、早产、严重产后出血和胎儿畸形的风险升高相关;中度或重度贫血还与母亲休克、入住ICU相关,重度贫血还与死胎相关;轻度贫血则与母亲休克、入住ICU、母亲死亡、胎儿生长受限和死胎的风险降低相关。作者认为,妊娠期贫血与母婴健康结局相关,轻度贫血与母婴生存及胎儿生长改善相关,尚需进一步研究验证实现最佳母婴健康的血红蛋白浓度。
要点
- 重度贫血(血红蛋白低于70 g/L)与严重产后出血风险显著升高相关(校正OR 15.65,95%CI 15.10-16.22),也与母亲休克相关(校正OR 14.98,95%CI 13.91-16.13)。
- 重度贫血与胎盘早剥相关(校正OR 3.35,95%CI 3.17-3.54),也与死胎相关(校正OR 1.86,95%CI 1.75-1.98),中度贫血则与死胎风险降低相关(校正OR 0.79,95%CI 0.76-0.81)。
- 重度贫血与入住ICU相关(校正OR 2.88,95%CI 2.55-3.25),中度贫血与入住ICU的关联较弱(校正OR 1.08,95%CI 1.01-1.16)。
- 轻度贫血(100至109 g/L)与母亲休克、入住ICU、母亲死亡、胎儿生长受限和死胎的风险降低相关,例如母亲死亡校正OR 0.37(95%CI 0.29-0.49)、死胎校正OR 0.59(95%CI 0.58-0.61)。
- 贫血严重程度越高,早产风险越高:轻度校正OR 1.08(95%CI 1.07-1.08)、中度1.18(95%CI 1.17-1.19)、重度1.36(95%CI 1.32-1.41)。
适用人群与场景
- 中国大陆1508家有产科服务的医院中,2016年1月1日至2019年12月31日期间15至49岁、已报告分娩结局的孕妇,数据来自中国医院质量监测系统。
诊断标准与关键阈值
- 妊娠期贫血按血红蛋白浓度分级:轻度为100至109 g/L,中度为70至99 g/L,重度为低于70 g/L;贫血诊断依据每日标准化电子住院出院记录中《国际疾病分类第十版》相应编码识别。
红旗征与不能漏的情况
- 重度贫血(血红蛋白低于70 g/L)与严重产后出血(校正OR 15.65,95%CI 15.10-16.22)、母亲休克(校正OR 14.98,95%CI 13.91-16.13)、入住ICU(校正OR 2.88,95%CI 2.55-3.25)、胎盘早剥(校正OR 3.35,95%CI 3.17-3.54)、死胎(校正OR 1.86,95%CI 1.75-1.98)风险升高相关。
研究设计与关键结果
- 研究类型为回顾性队列研究,数据来自中国医院质量监测系统2016年1月1日至2019年12月31日、1508家医院,纳入18 948 443例15至49岁孕妇(平均[SD]年龄29.42[4.87]岁)。
- 17.78%诊断妊娠期贫血,其中轻度9.04%、中度2.62%、重度0.21%、严重程度不明5.90%;采用多因素logistic回归估计校正OR及95%CI。
- 与无贫血相比,胎盘早剥:轻度校正OR 1.36(95%CI 1.34-1.38)、中度1.98(95%CI 1.93-2.02)、重度3.35(95%CI 3.17-3.54)。
- 与无贫血相比,早产:轻度校正OR 1.08(95%CI 1.07-1.08)、中度1.18(95%CI 1.17-1.19)、重度1.36(95%CI 1.32-1.41)。
- 与无贫血相比,严重产后出血:轻度校正OR 1.45(95%CI 1.43-1.47)、中度3.53(95%CI 3.47-3.60)、重度15.65(95%CI 15.10-16.22)。
- 与无贫血相比,胎儿畸形:轻度校正OR 1.15(95%CI 1.14-1.17)、中度1.19(95%CI 1.16-1.21)、重度1.62(95%CI 1.52-1.73)。
- 与无贫血相比,中度或重度贫血与母亲休克(中度校正OR 1.50[95%CI 1.41-1.60]、重度14.98[95%CI 13.91-16.13])、入住ICU(中度1.08[95%CI 1.01-1.16]、重度2.88[95%CI 2.55-3.25])、母亲死亡(中度0.45[95%CI 0.30-0.65]、重度1.56[95%CI 0.97-2.48])、胎儿生长受限(中度0.80[95%CI 0.78-0.82]、重度1.08[95%CI 1.00-1.17])、死胎(中度0.79[95%CI 0.76-0.81]、重度1.86[95%CI 1.75-1.98])相关。
- 与无贫血相比,轻度贫血与母亲休克(校正OR 0.67,95%CI 0.63-0.71)、入住ICU(校正OR 0.80,95%CI 0.76-0.84)、母亲死亡(校正OR 0.37,95%CI 0.29-0.49)、胎儿生长受限(校正OR 0.79,95%CI 0.77-0.80)、死胎(校正OR 0.59,95%CI 0.58-0.61)风险降低相关,以上均校正社会人口学特征和其他妊娠并发症。
证据类型、等级与局限
- 证据类型:回顾性队列研究;局限:原文未报告局限性(原文结论提出尚需进一步研究验证实现最佳母婴健康的血红蛋白浓度)。
对床旁实践的改变
- 作者认为,妊娠期贫血与母婴健康结局相关,轻度贫血与母婴生存及胎儿生长改善相关;作者提出尚需进一步研究验证实现最佳母婴健康的血红蛋白浓度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Anemia is the most widespread nutritional deficiency among pregnant females in the world. Despite numerous studies on anemia, evidence is limited about the association of severity of anemia with maternal and fetal health.
OBJECTIVE: To investigate the association between severity of anemia during pregnancy and risk of maternal and fetal adverse outcomes.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from China's Hospital Quality Monitoring System from January 1, 2016, to December 31, 2019, for pregnant females aged 15 to 49 years with birth outcomes reported at 1508 hospitals with maternity services in mainland China.
EXPOSURES: Anemia of varying severity during pregnancy was identified from daily standardized electronic inpatient discharge records using corresponding codes of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. Mild anemia was defined as a hemoglobin concentration of 100 to 109 g/L (to convert g/L to g/dL, divide by 10.0); moderate anemia, as 70 to 99 g/L; and severe anemia, as less than 70 g/L.
MAIN OUTCOMES AND MEASURES: The main outcomes included 6 maternal outcomes (placental abruption, preterm birth, severe postpartum hemorrhage, shock, admission to the intensive care unit [ICU], and maternal mortality) and 3 neonatal outcomes (fetal growth restriction, malformation, and stillbirth). Multivariable logistic regression models were used to estimate the odds ratios (ORs) and 95% CIs of these outcomes among pregnant females with varying severity of anemia.
RESULTS: Among 18 948 443 pregnant females aged 15 to 49 years (mean [SD] age, 29.42 [4.87] years), 17.78% were diagnosed with anemia during pregnancy, including 9.04% with mild anemia, 2.62% with moderate anemia, 0.21% with severe anemia, and 5.90% with anemia of unknown severity. Compared with no anemia, anemia severity during pregnancy was associated with increased risks of placental abruption (mild: adjusted OR [aOR], 1.36 [95% CI, 1.34-1.38]; moderate: aOR, 1.98 [95% CI, 1.93-2.02]; severe: aOR, 3.35 [95% CI, 3.17-3.54]), preterm birth (mild: aOR, 1.08 [95% CI, 1.07-1.08]; moderate: aOR, 1.18 [95% CI, 1.17-1.19]; severe: aOR, 1.36 [95% CI, 1.32-1.41]), severe postpartum hemorrhage (mild: aOR, 1.45 [95% CI, 1.43-1.47]; moderate: aOR, 3.53 [95% CI, 3.47-3.60]; severe: 15.65 [95% CI, 15.10-16.22]), and fetal malformation (mild: aOR, 1.15 [95% CI, 1.14-1.17]; moderate: aOR, 1.19 [95% CI, 1.16-1.21]; severe: aOR, 1.62 [95% CI, 1.52-1.73]). Compared with no anemia, moderate or severe anemia were associated with increased risks of maternal shock (moderate: aOR, 1.50 [95% CI, 1.41-1.60]; severe: aOR, 14.98 [95% CI, 13.91-16.13]), ICU admission (moderate: aOR, 1.08 [95% CI, 1.01-1.16]; severe: aOR, 2.88 [95% CI, 2.55-3.25]), maternal death (moderate: aOR, 0.45 [95% CI, 0.30-0.65]; severe: aOR, 1.56 [95% CI, 0.97-2.48], fetal growth restriction (moderate: aOR, 0.80 [95% CI, 0.78-0.82]; severe: aOR, 1.08 [95% CI, 1.00-1.17]), and stillbirth (moderate: aOR,0.79 [95% CI, 0.76-0.81]; severe: aOR, 1.86 [95% CI, 1.75-1.98]), and mild anemia was associated with decreased risks (maternal shock: aOR, 0.67 [95% CI, 0.63-0.71]; ICU admission: aOR, 0.80 [95% CI, 0.76-0.84]; maternal death: aOR, 0.37 [95% CI, 0.29-0.49]; fetal growth restriction: aOR, 0.79 [95% CI, 0.77-0.80]; stillbirth: aOR, 0.59 [95% CI, 0.58-0.61]) after adjusting for sociodemographic characteristics and other complications during pregnancy.
CONCLUSIONS AND RELEVANCE: The findings suggest that anemia during pregnancy is associated with maternal and fetal health outcomes and that mild anemia is associated with improved maternal and fetal survival and fetal growth. Further work is needed to validate the concentration of hemoglobin at which optimal maternal and fetal health are achieved.
参考来源
- Shi H, Chen L, Wang Y, et al. Severity of Anemia During Pregnancy and Adverse Maternal and Fetal Outcomes. JAMA Netw Open. 2022. PMID: 35113162. doi:10.1001/jamanetworkopen.2021.47046
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。